Skip to content
close icon

Prevent-HF with BaxDuo

NO LONGER ACCEPTING APPLICATIONS
Published on:
December 16, 2025
Sign-up Expiration:
Updated:
Topics:
Heart Health
Heart Failure
Dr. Naresh Mori
Locations:
Dr. Naresh Mori
Fort Mill, SC

A phase III study to investigate the risk of Incident Heart Failure and Cardiovascular Death with Baxdrostat in combination with Dapagliflozin in participants with increased risk of developing heart failure. BaxDuo Prevent-HF study is testing to prevent new cases of heart failure and CV death in high-risk patients with Type 2 Diabetes, Hypertension, and Cardiovascular Disease.

View Additional Information
View Clinical Trial Attachment
Sign Up NowExpired - View Other Trials
ENDED

Other Enrolling Clinical Trials

View All Enrolling Trials
Female Pattern Baldness - Thinning of the Hair

Living with Pattern Hair Loss Ladies????

View Trial
Systemic Lupus Erythmatosus

This study aims to examine the efficacy and safety of Obexelimab in participants with systemic lupus erythematosus (SLE).

View Trial
Adult Observations Study for Schizophrenia

View Trial
Sjögren Syndrome - RESOLVE

The purpose of the study is to evaluate the impact of RSLV-132 on dryness, tiredness/fatigue and pain in female participants with primary Sjögren's syndrome (pSS) with moderate to severe symptom burden and to assess its safety and tolerability.

View Trial
Adults with Active Psoriatic Arthritis and Obesity

This study is to find out if by lowering weight we can reduce the symptoms of Psoriatic Arthritis.

View Trial
Adults with Moderate-to-Severe Plaque Psoriasis and Obesity

This study to see if weight loss improves plaque psoriasis

View Trial

Sign-Up, Make an Appointment, or Receive More Information

Thank you for your interest in our clinical research trials. Please enter your contact information below and someone will reach out to you shortly to see if you qualify. You can also call us at 1-800-785-3150 or email participate@onsiteclinical.com

By submitting this form, you are consenting to be contacted by: OnSite Clinical Solutions, LLC, 11220 Elm Lane Suite 200 Charlotte, NC 28277. SMS message frequency varies. Message and data rates may apply. To stop receiving messages, reply STOP to opt out of all future messages.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.